Skip to main content
. 2023 Sep 13;17(1):315–327. doi: 10.1007/s12602-023-10151-w

Fig. 2.

Fig. 2

The change over time in the percentage of study participants (PP population) with a clinically relevant (> 30%) reduction vs. baseline in the TISS